Abstract
We have attempted to increase the efficacy of available chemotherapy for head and neck cancer through modulation of 5-FU. We took the combination of Cisplatin and 5-Fluorouracil as our base, since it had proven activity and a moderate toxicity profile that might allow for modulation [1, 2]. Our goal was to identify a regimen that would have a higher degree of activity resulting in improved survival.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rooney M, Kish J, Jacobs J et al (1985) Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55: 1123–1128
Yokes EE, Mick R, Lester EP, Panje WR, Weichselbaum RR (1991) Cisplatin and 5-Fluorouracil does not yield longterm benefit in locally advanced head and neck cancer: results from a single institution (in preparation)
Yokes EE, Moran WJ, Mick R, Weichselbaum RR, Panje WR (1989) neo-adjuvant and adjuvant methotrexate, cisplatin and fluorouracil in multimodal therapy of head and neck cancer. J Clin Oncol 7: 838–845
Yokes EE, Panje WR, Mick R, Kozloff MF, Moran WJ, Sutton HG, Goldman MD, Tybor AG, and Weichselbaum RR (1990) A randomized study comparing two regimens of neo-adjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer. Cancer 66: 206–213
Vokes EE, Choi KE, Schilsky RL, Moran WJ, Guarnieri CM, Weichselbaum RR, and Panje WR (1988) Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer. J Clin Oncol 6: 618–626
Yokes EE, Schilsky RL, Weichselbaum RR, Panje WR (1990) Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 8: 241–247
Yokes EE, Panje WR, Mick R, Haraf DJ, Moran WJ, McEvilly JM, Kozloff M, Weichselbaum (1990) neo-adjuvant chemotherapy surgery and concomitant chemoradiotherapy for locally advanced head and neck cancer. Proc ASCO 9: 174
Dreyfuss AI, Clark JR, Wright JE, Norris CM, Jr, Busse PM, Lucarini JW, Fallon BG, Casey D, Andersen JW, Klein R, Rosowsky A, Miller D, Frei E, III (1990) Continuous infusion high-dose leucovorin with 5-Fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Annals of Internal Medicine 112: 167–172
Vokes EE and Weichselbaum RR (1990) Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 8: 911–934
Yokes EE, Panje WR, Schilsky RL, Mick R, Moran WJ, Awan AM, Goldman MD, Tybor AG, Weichselbaum RR (1989) Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II Study. J Clin Oncol 7: 761–768
Haraf DJ, Yokes EE, Panje WR, Weichselbaum RR (1990) Survival and analysis of failure following hydroxyurea, 5-Fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer. Am J Clin Oncol (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag France
About this paper
Cite this paper
Vokes, E.E., Panje, W.R., Weichselbaum, R.R. (1991). 5-Fluorouracil modulation in head and neck cancer. In: Banzet, P., Holland, J.F., Khayat, D., Weil, M. (eds) Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy. Springer, Paris. https://doi.org/10.1007/978-2-8178-0782-9_13
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0782-9_13
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0784-3
Online ISBN: 978-2-8178-0782-9
eBook Packages: Springer Book Archive